Pfizer CEO: AstraZeneca drugs warning 'red herring'

Ian Read, chief executive of Pfizer, hit back at claims some of AstraZeneca's drugs may be delayed if Pfizer is successful in its bid for the company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.